Historique
Périodique
Acceptability of formulations and application methods for vaginal microbicides among drug-involved women: results of product trials in three cities
Auteur(s) :
HAMMETT, T. M. ;
MASON, T. H. ;
JOANIS C. L. ;
FOSTER, S. E. ;
HARMON P. ;
ROBLES, R. R. ;
FINLINSON, H. A. ;
FEUDO R. ;
VINING-BETHEA S. ;
JETER G. ;
MAYER, K. H. ;
DOHERTY-IDDINGS, P. ;
SEAGE G. R., 3RD.
Année
2000
Page(s) :
119-126
Langue(s) :
Anglais
Refs biblio. :
39
Domaine :
Drogues illicites / Illicit drugs
Discipline :
MAL (Maladies infectieuses / Infectious diseases)
Thésaurus mots-clés
ACCEPTABILITE
;
REDUCTION DES RISQUES ET DES DOMMAGES
;
SEXE FEMININ
;
VIH
;
PREVENTION
;
SEXUALITE
;
PRODUIT ILLICITE
Thésaurus géographique
ETATS-UNIS
Note générale :
Sexually Transmitted Diseases, 2000, 27, (2), 119-126
Résumé :
BACKGROUND AND OBJECTIVES: Female-controlled methods of HIV prevention, such as vaginal microbicides, are urgently needed, particularly among drug-involved women. Acceptability research is critical to product development. GOAL: To assess the acceptability of forms and application methods for future microbicides. DESIGN: Eighty-four drug-involved women were introduced in groups to three lubricant products, asked to try each for 3 weeks, and scheduled for individual follow-up interviews. RESULTS: Participants and their partners felt positive about the products, and expressed willingness to use microbicides if they were shown to be effective against HIV. Women agreed on product characteristics that influenced their reactions (e.g. ease of insertion, degree of "messiness"), but often disagreed on whether their reactions to these characteristics were positive or negative. CONCLUSION: Development of acceptable and effective HIV-prevention products depends on understanding the interaction between characteristics of the products and the characteristics and perceptions of women. Levels of sexual risk and acceptability factors based on drug-use patterns, race and ethnicity, culture, age, and types and attitudes of male partners suggest that a "one size fits all" approach will not win broad acceptance among drug-involved women. (Author' s abstract)
Affiliation :
Abt Associates Inc, Cambridge, Massachusetts 02138-1168.
Etats-Unis. United States.
Etats-Unis. United States.
Cote :
A03615